Improving how adults with COPD and asthma stick to and use their inhalers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter prospective observation-interventional project enrolling about 800 outpatients and nursing home residents with COPD or bronchial asthma and 200 healthcare professionals. It uses a validated Five Steps Assessment tool plus artificial intelligence methods to develop, implement, and validate a mobile/web app for patients and clinicians. Interventions include training on inhalation technique, educational materials, telephone/online contact, e-learning for professionals, and repeated follow-up to measure change. The study will compare adherence and technique before and after the interventions across participating sites.

Why it matters

Who can join: the full rules

PATIENTS

Inclusion Criteria:

1. signed informed consent,
2. age ≥ 18 years,
3. previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
4. ability to cooperate,
5. at least 8 weeks without exacerbation,
6. use of a particular inhaler for at least 3 months.

Exclusion Criteria:

1. pre-terminal/terminal stage of any disease,
2. uncooperative patient,
3. significant limitation of mobility or cognitive functions.

HEALTHCARE PROFESSIONALS

Inclusion Criteria:

1. signed informed consent,
2. completed education in medicine, pharmacy, or nursing,
3. more than one year of working experience,
4. care for patients taking inhaled therapy for BA/COPD.

Where it's running

• University Hospital Hradec Králové
  Hradec Králové, Czechia Recruiting

Study contacts

• Study coordinator: Josef Malý, Assoc. Prof. PhD.
• Email: malyj@faf.cuni.cz
• Phone: 00420 495 067 421

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• IOS-based platform to screen, diagnose, and manage COPD and asthma

  This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.

  Recruiting Beijing Chao Yang Hospital · Beijing, Beijing Municipality · NCT07910409

• Targeted NMES to improve breathing and leg/extra muscle strength in COPD

  This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.

  Recruiting Universitas Padjadjaran · Bandung, West Java · NCT07910006

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

• PBMT with a pulmonary rehab program for COPD patients

  A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.

  Recruiting Federal University of Health Science of Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07878884

• Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation

  This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.

  Recruiting Hôpital Universitaire Taher Sfar · Mahdia, Mahdia Governorate and 1 other locations · NCT07842510

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.